Intravitreal Aflibercept Injection vs Sham in AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-Risk Eyes: A Randomized Clinical Trial
JAMA Ophthalmol 2021 Mar 18;[EPub Ahead of Print], JS Heier, DM Brown, SP Shah, N Saroj, S Dang, NK Waheed, CC Wykoff, JL Prenner, DS BoyerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.